Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism KCNIP4 inhibitors(potassium voltage-gated channel interacting protein 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H19NO4 |
InChIKeyIQCQHKPTTDSXSZ-UHFFFAOYSA-N |
CAS Registry1956337-58-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | ES | 04 Feb 2019 |